A new medical test developed by Renatech Co. Ltd. Is now available at the Komatsuna Comprehensive Medical Clinic in Mie Prefecture. The "Metal Balance Test" uses just 6 mL of blood to assess the risk of cancer and mild cognitive impairment (MCI). The test is set to begin accepting reservations from December.
The test analyzes blood samples to detect imbalances in metal elements, which are linked to early signs of cancer and cognitive decline. Early detection of these conditions can lead to more effective treatment and better patient outcomes. The clinic has partnered with Renatech to offer this innovative service, marking a significant advancement in preventive healthcare.
This development follows growing interest in non-invasive diagnostic tools that can provide early warnings of serious health conditions. Renatech has been working on the technology for several years, with clinical trials showing promising results. The Metal Balance Test is part of a broader initiative to improve early diagnosis and personalized treatment plans. The availability of the test in Mie Prefecture is expected to increase access to advanced diagnostic services for local residents.
